APYX vs DVA · rev $48.1M vs P/E 14, rev $12.82B
Apyx Medical Inc (APYX) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
APYX currently screens at market cap $179.6M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the APYX and DVA stock pages for the full models.
Not investment advice.